GL1X · GenesisL1 explorer

MolNFT v1 · #137711 · protein

Bak core latch dimer in complex with bim-H3PC-rt

5VWY · BCL-2 homologous ANTAGONIST/KILLER: “Bak core latch dimer in complex with bim-H3PC-rt”. X-ray diffraction, 1 ligand (PO4), 2 pockets (best druggability 0.40). MolNFT v1 #137711 on GenesisL1: 3D structure, binding sites and pockets…

PDB
5VWY
Type
protein
Length
178 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
BCL-2 homologous ANTAGONIST/KILLER; BCL-2-like protein 11
UniProt
Q16611, O43521
Ligands
PO4
Pockets
2 · best druggability 0.40

Structure

x-ray diffraction · 2 distinct chains · 76% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABCL-2 homologous ANTAGONIST/KILLERprotein15375% helix, 0% strandQ16611
BBCL-2-like protein 11protein2580% helix, 0% strandO43521

Ligands and binding sites

  • PO4 · Phosphate ion · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1770.400.7912empty
2780.340.7523empty

Interfaces

1 interface between chains.

  • A–B · 1149 Ų buried · 23 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (nonstandard).

Compared structures

  • 5VWY · Bak core latch dimer in complex with Bim-h3Pc-RT · the same entry in another collection · chain A against A, TM-score 1.00
  • O43521 · AlphaFold monomer V2.0 prediction for BCL-2-like protein 11 (O43521) · a predicted model of the same protein · chain B against A, TM-score 0.81
  • Q16611 · AlphaFold monomer V2.0 prediction for BCL-2 homologous ANTAGONIST/KILLER (Q16611) · a predicted model of the same protein · chain A against A, TM-score 0.72

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.